Review Article
The Role of Secondary Surgery in Recurrent Ovarian Cancer
Table 2
Multivariate analysis for survival.
| | Zang | Eisenkop | Tay | Zang | Onda | Pfisterer | Ayhan | [16] | [13] | [15] | [16] | [17] | [19] | [20] |
| n | 60 | 106 | 46 | 107 | 44 | 267 | 64 | Age | | Ns | | Ns | Ns | | Ns | PS | | Ns | | | Ns | | Ns | Initial FIGO | Ns | | Ns | Ns | Ns | | Ns | Grade | Ns | Ns | Ns | | | | Ns | Histology | Ns | | | 0.017 | Ns | | 0.005 | RD after primary surgery | | | | Ns | Ns | | 0.003 | DFI | 0.0116 | 0.005 | 0.001 | | | <0.001 | 0.003 | RD after secondary surgery | 0.0041 | 0.007 | 0.002 | | | <0.001 | 0.04 | Disease localization | | Ns | | | 0.013 | | | No disease sites | | | | | <0.001 | | | Largest tumor diameter | Ns | 0.04 | | | <0.001 | | | Ascites1 | 0.0191 | Ns | | | Ns | 0.012 | | Ca 1251 | | Ns | | | | | | No cycles chemo2 | Ns | | | | | | | Chemo2 | Ns | 0.001 | | | | | |
|
|
Ns: not significant, RD: residual disease, DFI: disease-free interval.
1At secondary surgery.
2Prior to secondary surgery.
|